Skip to main content
Clinical Trials/NCT07144683
NCT07144683
Recruiting
Not Applicable

Risk Factors for Anastomotic Leakage After Colorectal Surgery.

Minia University1 site in 1 country430 target enrollmentStarted: August 25, 2025Last updated:

Overview

Phase
Not Applicable
Status
Recruiting
Sponsor
Minia University
Enrollment
430
Locations
1
Primary Endpoint
Incidence of Anastomotic Leakage (AL)

Overview

Brief Summary

Anastomotic leakage (AL) is a severe complication after colorectal surgery, with incidence rates of 2-30%. This prospective, single-center observational cohort study aims to identify and quantify independent risk factors for AL, determine its incidence and impact on outcomes, and develop a predictive model. Approximately 430 patients undergoing colorectal resection with anastomosis will be enrolled from August 2025 to August 2026. Risk factors will be assessed preoperatively, intraoperatively, and postoperatively. AL will be defined and graded per the International Study Group of Rectal Cancer (ISGRC) criteria.

Detailed Description

Anastomotic leakage (AL) remains a major complication after colorectal surgery, contributing to morbidity, mortality, prolonged hospital stays, and increased costs. Its etiology is multifactorial, involving patient, disease, and surgical factors. This study will prospectively evaluate risk factors in a single-center setting to minimize variability.

AL definition (per ISGRC): Defect at anastomotic site causing communication between intra/extraluminal compartments and luminal tract, diagnosed via clinical signs (e.g., peritonitis, fecal discharge), radiological evidence (e.g., CT showing extraluminal air/contrast or fluid collection), or operative verification.

Severity grading:

  • Grade A: Asymptomatic/mild, no active treatment.
  • Grade B: Requires intervention (e.g., drainage, antibiotics) but no reoperation.
  • Grade C: Requires reoperation.

Risk factors categorized as:

  • Preoperative: Demographics (age, sex, BMI), comorbidities (ASA score, diabetes, etc.), lifestyle (smoking, alcohol), nutritional status (albumin, CRP), neoadjuvant therapy, medications, diagnosis (e.g., cancer, tumor location), and bowel preparation.
  • Intraoperative: Approach (open/laparoscopic), resection type, anastomosis details (hand-sewn/stapled, level, perfusion assessment), peritoneal soiling, diverting stoma, operative time, blood loss/transfusion, drainage, surgeon experience, complications.
  • Postoperative: AL diagnosis/severity/management, inflammatory response (CRP, WBC), anemia, complications (ileus, infection), hospital stay, nutritional support, mobilization, reoperation, ICU stay, mortality, pain management.Early detection of leak using inflammatory markers either in the serum or drain fluid. Drain fluid inflammatory markers (Drain Fluid Calprotectin(CP), Drain Fluid C-Reactive Protein (CRP), Drain Fluid Procalcitonin)and Serum inflammatory markers(Serum C-Reactive Protein (CRP), Serum Procalcitonin (PCT), Serum Lactate dehydrogenase (LDH)).

Data from electronic records, surgical notes, nursing charts, and follow-up. Statistical analysis includes descriptive stats, univariate/multivariate logistic regression for risk factors, subgroup analyses, and predictive model development/validation.

The study adheres to the Helsinki Declaration and Good Clinical Practice (GCP). Informed consent is required.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged ≥18 years
  • Undergoing elective or emergency colorectal resection with primary anastomosis (e.g., ileocolic, colocolic, colorectal, coloanal)
  • Providing written informed consent

Exclusion Criteria

  • Colorectal resection without anastomosis (e.g., end stoma)
  • Inflammatory bowel disease (Crohn's, ulcerative colitis)
  • History of previous colorectal surgery involving anastomosis
  • Pregnancy
  • Unable to provide informed consent or comply with follow-up

Outcomes

Primary Outcomes

Incidence of Anastomotic Leakage (AL)

Time Frame: Within 30 days post-surgery.

Proportion of patients developing AL within 30 days post-surgery or during hospital stay (whichever longer), diagnosed clinically, radiologically, or operatively per ISGRC definition

Secondary Outcomes

  • Severity of Anastomotic Leakage(Within 30 days post-surgery)
  • Reoperation Rate Due to AL(Within 30 days post-surgery)
  • Readmission Rate Due to AL(Within 30 days post-surgery)
  • Length of Hospital Stay(Within 30 days post-surgery.)
  • Mortality Rate(Within 30 days post-surgery.)
  • Need for Permanent Stoma(Within 90 days post-surgery)

Investigators

Sponsor
Minia University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Saleh Khairy Saleh MD

Lecturer

Minia University

Study Sites (1)

Loading locations...

Similar Trials